Early results following everolimus-eluting bioresorbable vascular scaffold implantation for the treatment of in-stent restenosis.
Cardiology Department, Bolognini Hospital, Seriate (BG), Italy.
Alfonso
A
Ielasi
Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; San Raffaele Scientific Institute, Milan, Italy.
Azeem
A
Latib
Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; San Raffaele Scientific Institute, Milan, Italy.
Toru
T
Naganuma
Catetherization Laboratory, Fatebenefratelli Hospital, Milan, Italy.
Bernardo
B
Cortese
Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; San Raffaele Scientific Institute, Milan, Italy.
Katsumasa
K
Sato
Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; San Raffaele Scientific Institute, Milan, Italy.
Tadashi
T
Miyazaki
Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; San Raffaele Scientific Institute, Milan, Italy.
Vasileios F
VF
Panoulas
Cardiology Department, Bolognini Hospital, Seriate (BG), Italy.
Maurizio
M
Tespili
Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; San Raffaele Scientific Institute, Milan, Italy. Electronic address: info@emocolumbus.it.
Antonio
A
Colombo
D023903:Coronary Restenosis / Q000628:therapy*; D054855:Drug-Eluting Stents; D000068338:Everolimus; D006801:Humans; D008297:Male; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*; D054457:Tissue Scaffolds; D041623:Tomography, Optical Coherence
D000068338:Everolimus; D020123:Sirolimus
Bioresorbable vascular scaffold; In-stent restenosis; Percutaneous coronary intervention